Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

FDA Approves HPV Tests That Allow for Self-Collection in a Health Care Setting

Date PostedWednesday, July 24, 2024, by Sharon Reynolds

On May 14, the Food and Drug Administration (FDA) expanded the approvals of two tests that detect cancer-causing types of human papillomavirus (HPV) in the cervix. Both tests are used as part of screening for cervical cancer.

In this NCI Cancer Currents Blog DCP's Dr. Vikrant Sahasrabuddhe explains how the FDA's recent expanded approvals of self-collection devices for HPV screening relates to the recently launched SHIP (Self-collection for HPV testing to Improve Cervical Cancer Prevention) Trial.

Read the blog: https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-hpv-test-self-collection-health-care-setting